New endoscopic breast reconstruction could change surgery for cancer patients
NCT ID NCT06817954
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare two surgical approaches for breast cancer patients who need a mastectomy (breast removal) and immediate reconstruction. One group will have standard surgery, while the other will use a newer, endoscopic-assisted technique that may involve smaller incisions. Researchers will track 800 women over time to see which method leads to fewer cancer recurrences and complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
endoscopic-assisted mastectomy and immediate breast reconstruction (procedure)
What this could lead to
If successful, this could show that endoscopic-assisted surgery is a safe and effective option for breast reconstruction after mastectomy, potentially reducing scarring and recovery time.
What could go wrong
This is an early-stage exploratory study, so results may not confirm superiority over standard surgery. Risks include complications like infection, bleeding, or recurrence, and the technique may not suit all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital with Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••